The authors provide a concise overview of the prostate cancer metabolomics-based potential discriminating molecules in urine samples using nuclear magnetic resonance spectroscopy and mass spectrometry.
[Expert Review of Proteomics]
Sorry, but the selected Zotpress account can't be found.